Impact of Parathyroidectomy Versus Oral Cinacalcet on Bone Mineral Density in Patients on Peritoneal Dialysis With Advanced Secondary Hyperparathyroidism: The PROCEED Pilot Randomized Trial

被引:2
|
作者
Wang, Angela Yee-Moon [1 ]
Tang, Tak -Ka [1 ]
Yau, Yat-Yin [2 ]
Lo, Wai Kei [3 ]
机构
[1] Univ Hong Kong, Univ Dept Med, Queen Mary Hosp, 102 Pokfulam Rd, Hong Kong, Peoples R China
[2] Biomed Imaging Cente, Hong Kong, Peoples R China
[3] Tung Wah Hosp, Dept Med, Hong Kong, Peoples R China
关键词
CARDIOVASCULAR-DISEASE; TRABECULAR BONE; FRACTURES; TURNOVER; MARKERS; RISK;
D O I
10.1053/j.ajkd.2023.10.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rationale & Objective: Parathyroidectomy and calcimimetics have been used to reduce fracture risk in patients with kidney failure and advanced secondary hyperparathyroidism (SHPT), but direct comparisons of these treatment approaches have not been implemented. This pilot study compared their effects on bone mineral density (BMD) in this patient population. Study Design: A prospective pilot open-label randomized trial. Setting & Participants: 65 patients receiving maintenance peritoneal dialysis with advanced SHPT recruited from 2 university-affiliated hospitals in Hong Kong. Interventions: Total parathyroidectomy with forearm autografting versus oral cinacalcet treatment for 12 months. Outcome: Prespecified secondary end points including changes in BMD z and T scores of femoral neck, lumbar spine, and distal radius 12 months after treatment initiation and also categorized as osteopenia or osteoporosis according to the World Health Organization. Results: Both total parathyroidectomy and cinacalcet significantly improved BMD of the lumbar spine and femoral neck over 12 months, but the total parathyroidectomy group had a greater increase than the cinacalcet-treated group (P < 0.001). The proportion of study participants classified as having osteopenia/osteoporosis by femoral neck T-score fell from 78.2% to 51.7% in the total parathyroidectomy group (P < 0.001) and from 65.7% to 52.0% in cinacalcet-treated group after 12 months (P = 0.7). The proportion of participants with a T-score at the lumbar spine classified as osteopenia/osteoporosis fell from 53.1% to 31.0% in the total parathyroidectomy group (P = 0.01) and from 59.4% to 53.8% with cinacalcet (P = 0.3). No significant change was observed in BMD T or z score of the distal radius over 12 months with either intervention. Limitations: Bone histology was not assessed, and the study duration was 12 months. Conclusions: A large proportion of peritoneal dialysis patients with advanced SHPT had low bone densities and osteopenia/osteoporosis. Total parathyroidectomy increased the BMD of the lumbar spine and femoral neck and reduced osteopenia/osteoporosis more than oral cinacalcet.
引用
收藏
页码:456 / 466.e1
页数:12
相关论文
共 50 条
  • [21] Parathyroidectomy followed by kidney transplantation can improve bone mineral density in patients with secondary hyperparathyroidism
    Chou, Fong-Fu
    Hsieh, Kun-Chou
    Chen, Yen-Ta
    Lee, Chien-Te
    TRANSPLANTATION, 2008, 86 (04) : 554 - 557
  • [22] EFFECT OF CINACALCET HYDROCHLORIDE (CH) ON BONE MINERAL DENSITY IN HEMODIALYSIS (HD) PATIENTS WITH SECONDARY HYPERPARATHYROIDISM (SHPT)
    Ogata, Hiroaki
    Takeshima, Akiko
    Yamamoto, Masahiro
    Asakura, Kei
    Kato, Tadashi
    Shishido, Kanji
    Koiwa, Fumihiko
    Mizobuchi, Masahide
    Kinugasa, Eriko
    Akizawa, Tadao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 495 - 495
  • [23] The Impact of Observation Versus Parathyroidectomy on Bone Mineral Density and Fracture Risk Determined by FRAX Tool in Patients With Primary Hyperparathyroidism
    Khan, Rahim
    Martin, James
    Das, Gautam
    JOURNAL OF CLINICAL DENSITOMETRY, 2020, 24 (04) : 571 - 580
  • [24] The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyperparathyroidism: a meta-analysis
    Dan Li
    Leping Shao
    Haiyan Zhou
    Wei Jiang
    Wei Zhang
    Yan Xu
    Endocrine, 2013, 43 : 68 - 77
  • [25] Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: A prospective and randomized study
    Almqvist, EG
    Becker, C
    Bondeson, AG
    Bondeson, L
    Svensson, J
    SURGERY, 2004, 136 (06) : 1281 - 1287
  • [26] The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyperparathyroidism: a meta-analysis
    Li, Dan
    Shao, Leping
    Zhou, Haiyan
    Jiang, Wei
    Zhang, Wei
    Xu, Yan
    ENDOCRINE, 2013, 43 (01) : 68 - 77
  • [27] Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in Hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study
    Lindberg, JS
    Culleton, B
    Wong, G
    Borah, MF
    Clark, RV
    Shapiro, WB
    Roger, SD
    Husserl, FE
    Klassen, PS
    Guo, MD
    Albizem, MB
    Coburn, JW
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (03): : 800 - 807
  • [28] Comparative Analysis of Fracture Rates and Bone Density in Patients with Secondary Hyperparathyroidism: Parathyroidectomy versus Medical Management
    Simoni, Gabriel
    Castella, Vida
    Herculano, Breno
    Bertoli, Edmundo
    Aleksova, Jasna
    Rodriguez, Alexander Joseph
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 104 - 105
  • [29] Analysis of bone mineral density in patients with hyperparathyroidism secondary to end-stage renal disease and indication of parathyroidectomy
    Lacativa, PGS
    Salvarezza, B
    do Monte, CMG
    Mendonça, LMC
    Gonçalves, MDC
    Patricio, PJM
    Farias, MLF
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S29 - S29
  • [30] A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism
    Eddington, Helen
    Chinnadurai, Rajkumar
    Alderson, Helen
    Ibrahim, Sara T.
    Chrysochou, Constantina
    Green, Darren
    Erekosima, Ibi
    Hutchison, Alastair
    Bubtana, Abdalla
    Hegarty, Janet
    Kalra, Philip A.
    BMC NEPHROLOGY, 2021, 22 (01)